Toyosi Onwuemene/LinkedIn
Jun 11, 2026, 16:25
Toyosi Onwuemene: What Clinicians Reveal About Bleeding and Clotting Care
Toyosi Onwuemene, Associate Professor with tenure Duke University School of Medicine, shared a post on LinkedIn:
”A patient developed a pulmonary embolism.
He was started on anticoagulation.
Two days later, he developed gastrointestinal bleeding.
Anticoagulation was stopped.
Multiple specialists became involved.
One question remained:
When should anticoagulation be restarted?
It seemed like a straightforward question.
Yet, no one owned the decision.
In the latest edition of Hematology Access Insights, I explore what clinician interviews revealed about expertise, access, and decision-making in bleeding and clotting care.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Nov 4, 2026, 02:26Iris Paola Garcia Herrera: Antiphospholipid Antibodies in Children Beyond Thrombosis
-
Nov 4, 2026, 00:31Maria Cherska: Beyond LDL – Remnant Cholesterol and Stroke Prognosis
-
Nov 3, 2026, 22:00Ravi C Dara: What’s New in ASFA’s 10th Edition – Practical Updates for the Apheresis Clinician
-
Nov 3, 2026, 21:46Cedric Hermans: Treatment Differentiators for Shared Decision-Making in Haemophilia in 2026
-
Nov 3, 2026, 21:38Arwa Z. Al-Riyami: AI Opportunities and Future Directions in Transfusion Medicine
-
Nov 3, 2026, 21:11Yazan Abou-Ismail: Presenting at American College of Emergency Physicians and MWTCC in the Same Week
-
Nov 3, 2026, 21:05Anirban Sen Gupta: Escalating-Dose Lyophilized SynthoPlate for Emergency Trauma Mitigation
-
Nov 3, 2026, 20:50Mostafa Faisal Mohammed Saleh: Targeting Plasma Cells to Control Persistent ADAMTS13 Autoantibodies in iTTP
-
Nov 3, 2026, 16:57Ahmed Alotaibi: Which Macrophage Receptor ‘eats’ anti-E and Anti-K Coated RBCs?